Bayer Operating Income 2010-2025 | BAYRY

Bayer operating income for the twelve months ending March 31, 2025 was $-0.985B, a 219% decline year-over-year.

  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
  • Bayer annual operating income for 2022 was $7.388B, a 86.24% increase from 2021.

Bayer Operating Income 2010-2025 | BAYRY

  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
  • Bayer annual operating income for 2022 was $7.388B, a 86.24% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$748.5B
Johnson & Johnson (JNJ)$396.5B
AbbVie (ABBV)$336.6B
Novo Nordisk (NVO)$299.3B
Roche Holding AG (RHHBY)$256.4B
Novartis AG (NVS)$250B
Merck (MRK)$207B
Pfizer (PFE)$139.9B
Sanofi (SNY)$119B
Innoviva (INVA)$1.3B